A new 68Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging

Amino Acids

Volumn 46, Issue 6, 2014, Pages 1481-1489

  Pan, Donghui ^a   Xu, Yu Ping ^a   Yang, Rong Hua ^c   Wang, Lizhen ^a   Chen, Fei ^a   Luo, Shineng ^a   Yang, Min ^a   Yan, Yongjun ^b  

^a BEIJING HOSPITAL   (China)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Gastrin releasing peptide receptor; MATBBN; NOTA; Prostate tumor

Indexed keywords

BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; TRACER; 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; BOMBESIN RECEPTOR; GALLIUM; HETEROCYCLIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOACCUMULATION; CELL ASSAY; CONTROLLED STUDY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOLECULAR IMAGING; MOLECULAR STABILITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING; RADIOASSAY; RADIOCHEMISTRY; RADIOISOTOPE DECAY; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; DIAGNOSTIC USE; HUMAN; METABOLISM; NUDE MOUSE; PROCEDURES; PROSTATIC NEOPLASMS; TISSUE DISTRIBUTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALIA;

ANIMALS; BOMBESIN; CELL LINE, TUMOR; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HETEROGRAFTS; HUMANS; ISOTOPE LABELING; MALE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RECEPTORS, BOMBESIN; TISSUE DISTRIBUTION;

EID: 84901414418     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1718-y     Document Type: Article

References (27)

1. Ambrosini V, Fani M, Fanti S, Forrer F, Maecke HR (2011a) Radiopeptide imaging and therapy in Europe. J Nucl Med 52(Suppl 2):42S-55S
2. Ambrosini V, Fani M, Fanti S, Forrer F, Maecke HR (2011b) Radiopeptide imaging and therapy in Europe. J Nucl Med 52:42S-55S
3. Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH (2011) (99 m)technetium-HYNIC(tricine/TPPTS)- Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model. Mol Pharm 8(4):1165-1173. doi:10.1021/mp200014h
4. Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ et al (2011) (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives. Semin Nucl Med 41:314-321
5. Carroll RE, Ostrovskiy D, Lee S, Danilkovich A, Benya RV (2000) Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines. Mol Pharmacol 58:601-607
6. Chen X, Park R, Hou Y, Tohme M, Shahinian AH et al (2004) MicroPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3] bombesin in human prostate adenocarcinoma xenografts. J Nucl Med 45:1390-1397 (Pubitemid 47618540)
7. de Sá A, Matias AA, Prata MI, Geraldes CF, Ferreira PM et al (2010) Gallium labeled NOTA-based conjugates for peptide receptor-mediated medical imaging. Bioorgan Med Chem Lett 20:7345-7348
8. Dijkgraaf I, Franssen GM, McBride WJ, D'Souza CA, Laverman P et al (2012) PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. J Nucl Med 53:947-952
9. 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG. J Nucl Med 48(8):1245-1250
10. Dumont RA, Tamma M, Braun F, Borkowski S, Reubi JC, Maecke H, Weber WA, Mansi R (2013) Targeted radiotherapy of prostate cancer with a gastrin-releasing peptide receptor antagonist is effective as monotherapy and in combination with rapamycin. J Nucl Med 54:762-769
11. Fani M, Andre JP, Maecke HR (2008) 68 Ga-PET: a powerful generator based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 3:67-77
12. Fleischmann A, Waser B, Gebbers JO, Reubi JC (2005) Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. J Clin Endocrinol Metab 90:4722-4729 (Pubitemid 41159364)
13. Graham MM, Menda Y (2011) Radiopeptide imaging and therapy in the United States. J Nucl Med 52(Suppl 2):56S-63S
14. Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK et al (2003) Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nucl Med 44:823-831 (Pubitemid 39655218)
15. Lang L, Li W, Guo N, Ma Y, Zhu L et al (2011) Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem 22(12):2415-2422
16. Laverman P, Sosabowski JK, Boerman OC, Oyen WJ (2012) Radiolabelled peptides for oncological diagnosis. Eur J Nucl Med Mol Imaging 39:S78-S92
17. Lears KA, Ferdani R, Liang K, Zheleznyak A, Andrews R et al (2011) In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. J Nucl Med 52:470-477
18. Liu Z, Yan Y, Chin FT, Wang F, Chen X (2012) Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN. J Med Chem 18:11079-11087
19. Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi JC, Maecke HR (2011) Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging 38(1):97-107
20. Nanda PK, Pandey U, Bottenus BN, Rold TL, Sieckman GL, Szczodroski AF, Hoffman TJ, Smith CJ (2012) Bombesin analogues for gastrin-releasing peptide receptor imaging. Nucl Med Biol 39(4):461-471
21. Reubi JC, Korner M, Waser B, Mazzucchelli L, Guillou L (2004) High expression of peptide receptors as a novel target in gastrointestinal stromal tumours. Eur J Nucl Med Mol Imaging 31:803-810 (Pubitemid 38758349)
22. Reubi JC, Macke HR, Krenning EP (2005) Candidates for peptide receptor radiotherapy today and in the future. J Nucl Med 46:67S-75S (Pubitemid 47619021)
23. Roivainen A, Kähkönen E, Luoto P, Borkowski S, Hofmann B, Jambor I, Lehtiö K, Rantala T, Rottmann A, Sipilä H, Sparks R, Suilamo S, Tolvanen T, Valencia R, Minn H (2013) Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68 Ga bombesin antagonist BAY86-7548 in healthy men. J Nucl Med 54:867-872
24. Sancho V, Di Florio A, Moody TW, Jensen RT (2011) Bombesin receptor-mediated imaging and cytotoxicity: review and current status. Curr Drug Deliv 8:79-134
25. Schuhmacher J, Zhang H, Doll J, Mäcke HR, Matys R et al (2005) GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68 Ga-labeled bombesin (6-14) analog. J Nucl Med 46:691-699 (Pubitemid 41721868)
26. Yang M, Gao HK, Zhou YR, Ma Y, Quan QM et al (2011) 18F-labeled GRPR agonists and antagonists: a comparative study in prostate cancer imaging. Theranostics 1:220-229
27. Zhang X, Cai W, Cao F, Schreibmann E, Wu Y, Wu JC et al (2006) 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 47:492-501 (Pubitemid 46768492)